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Abstract
Background: Five-year survival on dialysis is only 40%, compared to 74% with a deceased donor kidney transplant
(DDKT) and 87% with a living donor kidney transplant (LDKT). An American Society of Transplantation (AST) Consensus
Conference recommended that patients with chronic kidney disease (CKD) Stages 3–5 have the opportunity to learn
about and decide which treatment option is right for them, particularly about LDKT. However, early education about
LDKT and DDKT outside of transplant centers is inconsistent and often poor, with patients in CKD 3 and 4 and ethnic/
racial minorities even less likely to receive it. A new randomized control trial (RCT), in partnership with Kaiser Permanente
Southern California (KPSC), will assess knowledge gaps and the effectiveness of a supplementary video-guided, print and
technology-based education intervention for English- and Spanish-speaking patients in CKD Stages 3, 4, and 5 to increase
LDKT knowledge and decision-making. To date, no published LDKT educational interventions have studied such a large
and diverse CKD population.
Methods: In this RCT, 1200 English and Spanish-speaking CKD Stage 3–5 patients will be randomly assigned to one of
two education conditions: ET@Home or KPSC standard of care education. Randomization will be stratified by CKD stage
and primary language spoken. Those in the ET@Home condition will receive brochures, postcards, DVDs, and text
messages delivering educational content in modules over a six-month period. Baseline data collection will measure
demographics, transplant derailers, and the amount of previous CKD and transplant education they have received.
Changes in CKD and transplant knowledge, ability to make an informed decision about transplant, and self-efficacy to
pursue LDKT will be captured with surveys administered at baseline and at six months.
Discussion: At the conclusion of the study, investigators will understand key knowledge gaps for patients along the
CKD continuum and between patients who speak different languages and have assessed the effectiveness of both
English- and Spanish-language supplementary education in increasing KPSC patients’ knowledge about the
opportunities for and risks and benefits of LDKT. We hope this program will reduce disparities in access to transplant.
(Continued on next page)
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Background
There are 30 million Americans with chronic kidney dis-
ease (CKD) and at risk for kidney failure, and 660,000
patients with end-stage renal disease (ESRD). To sustain
life, ESRD patients, 31% of whom are Black, 15% His-
panic, and 5% Asian, must either receive daily or weekly
dialysis treatments or have a kidney transplant. The
five-year survival rate for patients on dialysis is only
40%, compared to 74% for patients who receive a de-
ceased donor kidney transplant (DDKT) and 87% for pa-
tients who receive a living donor kidney transplant
(LDKT) [1]. Over 95,000 individuals are awaiting a
DDKT in the United States, with more being added daily
(based on OPTN data as of 06/08/2018).
Patients who receive kidney transplants live 5–15 years
longer than if they remained on dialysis and have a better
health-related quality of life (HRQOL), including a greater
likelihood of being in the workforce during their critical
earning years [2]. While LDKT is the medically optimal
and most cost-effective renal replacement therapy (RRT)
for patients with ESRD, LDKT rates have declined by 17%
from 2004 to 2014. In 2014, in the U.S., 17,106 patients re-
ceived a transplant (5536 LDKTs) while 8021 patients died
or became too ill to remain on the list; 70% who died were
racial/ethnic minorities. Of the 2281 transplants per-
formed in California in 2017, only 604 were from living
donors (OPTN data as of 06/08/2018).
Providing comprehensive education to CKD patients
about the benefits of LDKTas early as possible can increase
the chances that they will learn about it, seek living donors,
and ultimately receive an LDKT [3]. Many patients, par-
ticularly socioeconomically disadvantaged patients and pa-
tients of racial/ethnic minority groups [4], have not had
sufficient DDKT and LDKT education before their kidneys
failed. [5, 6] Generally, patients not considering LDKT lack
knowledge about the benefits of living donation over
remaining on dialysis [7], have concerns about involving
and risking a living donor’s health [7], fear asking others to
donate a kidney [8], or fear their own surgical pain and the
possibility of the transplanted kidney failing [9].
While Black and Hispanic patients experience higher
rates of diabetes and hypertension [5] and increased
chances of developing ESRD versus their White or
non-Hispanic counterparts [10], they are less likely to
complete transplant evaluation [6, 11, 12], experience lon-
ger wait-list times [13, 14], and are less likely to receive a
DDKT or LDKT [6, 10, 15, 16]. While 11.4% of White
patients had received an LDKT after two years of being
wait-listed, only 2.9 and 5.9% of Black and Hispanic pa-
tients, respectively, had received an LDKT [11, 17]. The dis-
parity in transplant knowledge between White patients and
patients of racial or ethnic minorities has been well docu-
mented by our research team [7, 8, 18, 19].
Without a nationally coordinated healthcare system in
the United States, it is difficult to ensure that patients mov-
ing from CKD Stages 3 and 4 to ESRD are consistently
making informed transplant decisions. Limited research is
available about how transplant education for patients in
CKD Stage 3 and 4 is delivered. One study in community
nephrologist’s offices, the Talking About Live Kidney Dona-
tion (TALK) program, compared the efficacy of an LDKT
print and video program, with or without in-person social
worker discussions, on CKD patients’ steps toward begin-
ning transplant evaluation [20]. Though the TALK trial
found that the discussion-oriented, social worker interven-
tion had a higher predicted probability of taking additional
steps in comparison to the education-only group, it also
found that significantly higher proportions of patients in
the education-only group took key steps towards trans-
plant, like completing transplant evaluation.
Effective strategies for transplant education within dialysis
centers are important to understand since 70% of ESRD pa-
tients are on dialysis [21], some of whom may never present
to a transplant center for evaluation. Our team surveyed
dialysis educators at 170 dialysis centers and found that
81% of educators were educating patients by recommend-
ing that they learn more about transplant by going to a
transplant center or learning about transplant themselves
[22]. In another study, only 24% (297 of 1223) of “in-
formed” patients (based on patient-reported data submitted
to the Centers for Medicare and Medicaid Services on
Form-2728) reported that educators had detailed discus-
sions about the risks and benefits of DDKTand LDKT with
them [22]. Other similar studies have found that less than
half of dialysis patients receive comprehensive discussions
or counselling about the risks and benefits of transplant
[22]. Our previous research has also shown that while kid-
ney patients spend over 500 h in the dialysis center annu-
ally, they only spend a median of one hour reading
brochures about transplant and 30min talking about trans-
plant with medical staff [4]. Only a minority of dialysis cen-
ters have formal education programs or provide transplant
education to share with potential living donors [22–24]. For
these and many other reasons, evidence suggests that not
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all dialysis patients receive appropriate information about
transplant [5, 6, 22, 23, 25].
Previous research has shown that two of the strongest
predictors of successful completion of transplant evalu-
ation are having access to more transplant education re-
sources and having greater transplant knowledge at the
onset of transplant evaluation, the latter also being the
only significant predictor for ultimately receiving an
LDKT [26]. With providers outside of transplant centers
reporting constraints to educating patients about trans-
plant [23], it is possible that providing supplementary
education within a large health care system, with its fully
integrated care management program, may be an oppor-
tune way to efficiently educate more CKD 3–5 patients
about the opportunities for and risks and benefits of
DDKT and LDKT. Further, the use of technology, such
as text messaging, videos, and digital applications may
reduce the provider burden barrier to delivering trans-
plant education.
There is previous evidence that delivering more com-
prehensive education over time may be helpful to patients
making informed decisions outside of transplant centers.
The RaDIANT program in Georgia which targeted dialy-
sis providers and patients with a multi-component educa-
tional intervention including patient educational toolkits,
videos, and a transplant mentoring program over one-year
found a 75% increased adjusted odds of referral for kidney
transplant evaluation and that the intervention activities
were more effective for Black versus White patients [27].
Through a group randomized controlled trial, a version of
Explore Transplant (ET) delivered face-to-face over four
meetings with patients while they were undergoing dialy-
sis, was shown to increase patients’ knowledge and in-
formed decision-making significantly more than standard
transplant education offered in dialysis centers [28]. Fi-
nally, Explore Transplant@Home (ET@Home) delivered
by mail and supported through bimonthly postcards and
texting over an eight-month period also found significant
increases in transplant knowledge and informed
decision-making among ESRD patients who received ET
in this format, compared with standard transplant educa-
tion in dialysis centers [29].
To date, ET and ET@Home have never been studied
with patients who are in CKD Stages 3 & 4 or with
Asian or Spanish-speaking patients. This study is a part-
nership between UCLA and Kaiser Permanente South-
ern California (KPSC). KPSC’s fully integrated care
management program, diverse membership, and ability
to track a large patient population offers a rare oppor-
tunity to study how knowledgeable CKD Stage 3–5 pa-
tients are about LDKT, assess disparities in knowledge
across many races, ethnicities, and languages, and con-
duct a large-scale trial of the effectiveness of ET@Home.
This manuscript will describe the protocol for a new
randomized control trial (RCT) conducted in collabor-
ation with KPSC to assess the effectiveness of ET@Home
within a large healthcare system with a diverse group of
CKD 3–5 patients.
Study design
The purpose of this study is to assess whether the
ET@Home program can be integrated successfully across
a large racially, ethnically, and geographically diverse pa-
tient catchment area and to assess its effectiveness to in-
crease knowledge about the risks and benefits of LDKT
and increase informed decision-making. The effective-
ness of the ET@Home program will be evaluated in a
randomized controlled trial (RCT) of 1200 Black, His-
panic, Asian, and White patients with stage 3, 4, or 5
CKD. Patients will be randomized to receive: (1) no add-
itional education other than what is provided within
KPSC (standard-of-care); or (2) a video-guided, four-part
ET@Home program delivered by mail and supported
through bimonthly postcards and texting over six
months. The study has two aims.
Aim 1
Before intervention, to assess differences in knowledge
and decision-making about the opportunities for and
risks and benefits of living kidney donation for 1200
CKD Stage 3–5 patients by race/ethnicity and primary
language spoken.
Hypothesis
Patients earlier in the CKD continuum, patients who
speak Spanish, and non-White patients will have less
knowledge about the opportunities for and risks and ben-
efits of living kidney donation and will be making less in-
formed LDKT decisions.
Aim 2
To conduct a randomized controlled trial in English and
Spanish of ET@Home for CKD Stage 3–5 patients to as-
sess its effectiveness to increase LDKT knowledge and
decision-making by race/ethnicity and primary language
spoken as compared to the standard KPSC education.
Hypothesis 1
At the conclusion of the trial, CKD patients who receive
ET@Home will have greater transplant knowledge and
be more likely to make an informed treatment decision
than patients receiving KPSC education alone.
Hypothesis 2
ET@Home will be more or equally effective for patients
earlier in the CKD continuum, patients who speak Span-
ish, and non-White patients than patients in these sub-
groups receiving KPSC education alone.
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Methods
Theoretical Foundation of ET@home
The Explore Transplant (ET) education program was
created based on Prochaska’s Transtheoretical Model of
Behavioral Change (TTM) and research with over 1000
patients with CKD, to address gaps in their transplant
knowledge [30]. ET allows transplant-eligible patients to
explore the option of remaining on dialysis or pursuing
DDKT or LDKT and make an informed choice after
knowing their benefits and risks. The TTM holds that
patients vary widely in their levels of readiness to make
important decisions about their health [31], like whether
or not to get an LDKT [32]. This study will employ edu-
cational resources from the ET@Home program that are
based on the TTM and that are designed to help CKD
patients at all stages of readiness and decision making
around DDKT and LDKT learn more about their treat-
ment options and to ultimately choose the option best
for them. The ET@Home educational resources never
pressure patients to pursue transplant of any kind; ra-
ther, they provide accurate information about the com-
plex set of potential risks and benefits that need to be
considered when deciding whether to get a DDKT or
LDKT, including potential increases in length and qual-
ity of life, resuming life activities, implications of taking
transplant medications, the chances of injury to a living
donor, and many more factors.
Study participants: Eligibility, recruitment, and
randomization
KPSC provides coverage and care to nearly 65,000 pa-
tients with CKD Stages 3–5 throughout Los Angeles,
San Diego, Kern, San Bernardino, Riverside, and Ventura
Counties. About 24% of these patients are Hispanic, 52%
White, 15% Black, and 9% Asian, similar to the broader
CKD population in California. As of December 2015,
more than 1500 KPSC CKD patients were listed on the
United Network for Organ Sharing (UNOS) waiting list
awaiting a DDKT, and approximately 700 additional
KPSC patients were undergoing transplant evaluation.
However, since 2014, only 350 KPSC patients have re-
ceived a kidney transplant, with fewer than 100 patients
receiving a LDKT.
Inclusion criteria for the study include adult KPSC pa-
tients between 18 and 70 years holding continuous
membership with KPSC, currently being treated for
CKD 3, 4, or 5/ESRD, having had at least one visit to a
KPSC nephrologist in the last 18 months and who speak
English or Spanish. To target enrollment of the CKD 3
patients at highest risk of worsening CKD, investigators
will calculate a risk score for CKD 3 patients using the
model described in Tangri et al. [33]
Exclusion criteria include having known medical or
other permanent contraindications to transplant including
cancer, heart failure, chronic obstructive pulmonary dis-
ease, hepatitis, cirrhosis, or dementia, or previous delisting
or rejection for renal transplant by a transplant center.
Other exclusion criteria include not being able to speak
and read English or Spanish or having previously received
a transplant. Those who have already refused to be
evaluated for a transplant will also be excluded from the
study. Patients’ transplant eligibility will be confirmed by
reviewing relevant information (e.g., absence of serious
heart disease or cancer) from their Kaiser electronic
medical record.
Prospective participants who meet eligibility criteria will
be sent an email inviting them to enroll in the study and
asked to complete the initial transplant decision-making
survey online or on the phone. Study staff will invite pa-
tients to participate in the RCT, beginning at the top of
the risk-score ranked list, moving down the list until
stratified cell targets are met. Recruitment will be stratified
by race/ethnicity, language spoken, and CKD stage, over-
sampling smaller subgroups within the KPSC patient
population. Expecting a response rate of 20%, an initial
sample of 6000 patients will be invited to participate,
resulting in a final sample of 1200 patients (Fig. 1). Click-
ing the survey link or contacting the study team by phone
to begin the survey indicates consent to participate in
the study. The email includes an opt out link if they
do not wish to participate in the study. Invited pro-
spective participants will receive follow-up invitations
by secure email and phone to complete the initial
transplant decision-making survey.
After completing the initial survey, enrolled partici-
pants will be randomized in a 1:1 ratio, stratified by
race/ethnicity, language spoken, and CKD stage, to
either the ET@Home intervention condition or standard
KPSC education. The randomization sequence is
produced electronically within the data capture system.
Once an enrolled participant is assigned to an interven-
tion arm, the study team will send the participant a noti-
fication of their assignment. Since this is an educational
intervention, neither the study participants nor the study
team are blinded to treatment assignment.
Settings
Since the CKD patients served by KPSC receive care in
13 KPSC centers spanning over 2000 mile2 ranging
across Los Angeles and San Diego metropolitan areas,
an intervention strategy and setting that can reach all of
these patients needs to be employed. Also, the interven-
tion needs to reach racial and ethnic minority patients,
who often have fewer transportation resources available
to them and may be less able to travel even locally to
take advantage of CKD education programs. Finally, the
DDKT and LDKT education program needs to be
flexible and capable of integration into the ongoing
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transplant education and care management programs
within KPSC so it does not create additional burden on
busy transplant coordinators and patient educators.
Thus, the setting for this Explore Transplant@Home trial
will be guided learning within the patient’s homes, for
patients and any interested individuals in their social
support networks, through use of video, print, and text
education.
Intervention (RCT educational components)
Description of standard KPSC transplant education (control)
All KPSC nephrology departments currently offer a 1–2
h course in transplant education to all CKD patients in-
terested in pursuing transplant, whether from a living or
deceased donor. The KPSC course addresses topics in-
cluding how kidney transplantation works, determining
whether kidney transplantation is the right choice, the
steps involved in pre-transplant evaluation and referral
to transplant centers of excellence. Because time is lim-
ited, the bulk of the content covered is oriented toward
developing an understanding of the evaluation and
wait-listing process, rather than on the risks and benefits
of pursuing LDKT. Patients are encouraged to bring any
prospective donors to the class with them, and course
attendees learn about the basics of donor testing, some
simple information regarding matching and donor ex-
changes, and reminders that LDKT can result in a much
shorter wait for a donor organ. Written materials and
presentations from the educators do recommend that
patients seek out living donors but do not provide de-
tails on how to approach prospective donors. The mate-
rials address only the risks and benefits to the recipient
not to the donors. Compared to DDKT, much less de-
tailed information is provided regarding LDKT, unless
prompted by interested patients. Practical information
about waiting for a transplant, including local wait-list
times and allocation criteria, the transplant procedure,
and steps for post-graft follow-up are covered in detail.
KPSC educators include nephrology nurses and social
workers. The course is presented monthly in English
with available real-time language interpreters at each of
13 local medical centers, in Spanish at 1–2 centers, and
is supplemented by a written pamphlet in English and
Spanish.
While patients at all phases of CKD and their family
members and support persons are welcome to attend
the transplant education course, it is primarily focused
on individuals who have reached an advanced stage of
CKD and/or ESRD and are contemplating renal replace-
ment options, or who are new to dialysis and consider-
ing transplant as a renal replacement approach. Patients
who wish to be evaluated for transplant eligibility and
move forward with the process of pre-transplant assess-
ment and listing are required to complete this course
before beginning pre-transplant work-up. For this trial,
routine transplant education practices will be continued
without any content changes. Patients who are random-
ized to the control condition and who are or become
potentially eligible for transplant will not receive any
additional interventions within KPSC during the study
period.
Description of patient-guided Explore Transplant@Home
program
Patients in the ET@Home study condition will receive
four modules of video and print transplant education
over a 6-month period (Table 1). The modules sequen-
tially help patients think through what is important to
them, learn what it might be like if they became a kidney
recipient or involved a living donor, the risks and
Fig. 1 Patient Recruitment Flowchart
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benefits of each, and, at the program’s conclusion, make a
decision about the best treatment option for them. The
four videos and their corresponding print brochures –
“Exploring Transplant”, “Kidney Recipients’ Transplant
Experiences,” “Living Donors’ Donation Experiences,” and
“Making an Informed Choice” – discuss in detail the med-
ical, psychological, and financial risks of being a deceased
or living donor. These modules cover ways to slow down
kidney disease and include real life quotes and stories
from people who have stayed on dialysis, received DDKT
and LDKT, or been a living donor. The “Making an In-
formed Choice” brochure is a decision aid that guides pa-
tients in choosing a path that is right for them and
provides helpful websites that patients can use as re-
sources to learn more. At the conclusion of the program,
patients individually choose which renal replacement
treatments may be right for them and plan a set of small
steps they want to take next.
To expand this program for patients in CKD 3 and 4,
we conducted a combination of 32 additional focus
groups and individual interviews to learn what additional
content should be added. Based on recommendations,
we added more content about the purpose and function
of kidneys, explaining in detail what kidney disease is
and its various stages, how to slow down the kidney fail-
ure process, and providing an overview of treatment op-
tions once the patient enters kidney failure. Experts
from the nonprofit organization, Health Literacy Media,
and the study investigators reviewed and revised all print
content using the most current, evidence-based health
literacy principles [34]. The review and edits included
considerations around audience appropriateness, read-
ability, behavioral orientation, interactivity, information
architecture, plain language, and clear design.
Each Explore Transplant@Home video begins and
ends with a transplant educator and kidney professional
or patient introducing the video and then making
specific recommendations afterwards about what to
think about next. The healthcare professionals on the
video are diverse in their gender and ethnicity. On the
final video of the series, a patient and his wife models
meeting with the educator to work through the
decision-aid and make a decision that is right for him or
her. This modeling occurs on the video to support the
patient watching and doing the same at home with his
family. The Spanish language version of the video
(voiced in Spanish, not subtitled) has been awarded a
certificate of translation.
During the baseline survey, patients will be asked
about the availability of Internet and DVD resources in
their home. If the patient does not have a DVD player, a
DVD player will be provided as a service of the grant.
Should they prefer to watch this program via Internet
streaming, an individualized login code will be provided
to them. Individual login data for patients utilizing the
Internet will be tracked to determine fidelity.
After each module of print and video education is
mailed, postcards will be mailed weekly, recapping
important content covered within the videos and bro-
chures. Patients will have the opportunity to participate
in a texting component of ET@Home that also sends
educational content through learning reminders and
questions by SMS text message each week (Table 2).
Study participants will receive text messages daily that
include study participation reminders, motivations to
continue in the study, CKD facts, recommendations for
learning more, and quiz questions to test knowledge.
Participation in the text messaging portion of the trial is
voluntary, and the option to opt out is available at all
times.
If patients have questions for their kidney and trans-
plant providers, they are directed to contact the
ET@Home Help line, which can connect them with their
KPSC providers for more information.
Involving social support network
Our general recommendation through the program will
be for patients to involve their family and friends in
learning and decision-making about transplant. The bro-
chures also recommend that the patient watch the video
with other people in their lives who help them make im-
portant health decisions, particularly the stories of living
donors, and complete the decision aid with them.
Variables
Before the intervention, a baseline patient survey will
measure the following independent variables: participants’
demographic characteristics, socioeconomic derailers to
Table 2 Examples of ET@Home Text Messages
REMINDER Your first packet “Basics of Kidney Disease” is headed your way! Keep an eye out for the postcards for this packet as well.
MOTIVATION You can slow down how fast your kidneys fail. Learn more about all of your options!
FACT Did you know that the kidneys help keep bones healthy?
RECOMMENDATION Chronic kidney disease (CKD) can present itself through a variety of symptoms. It’s important that you familiarize yourself with
these symptoms so you can track changes and talk to your doctor.
QUIZ QUESTION Can you slow down how fast your kidneys fail? Reply with YES or NO.
ANSWER FOR YES That’s right! You can slow down how fast your kidneys fail.
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pursuit of transplant, medical mistrust, health-related
quality of life (HRQOL), health literacy, and the amount
of previous transplant education they have received. It will
also assess the following dependent variables: level of
current transplant knowledge, current ability to make an
informed decision about transplant, self-efficacy to pursue
DDKT and LDKT, and steps taken toward transplant.
After the intervention, a post-survey will measure key
study dependent variables to assess change, including the
level of current transplant knowledge, current ability to
make an informed decision about transplant, self-efficacy
to pursue DDKTand LDKT, and steps taken toward trans-
plant. For patients randomized to receive the ET@Home
education, it will also assess their experiences with the
educational materials through a program evaluation
assessment.
Outcome measures and research methodology In
order to verify and demonstrate impact on improving
knowledge of the process, risks, advantages, and
disadvantages of deceased and living donation among
dialysis patients, an RCT will be conducted. In this
RCT, 1200 CKD patients in the KPSC system will be
randomized to one of two education conditions
(patient-guided ET@Home vs. standard KPSC
transplant education, 600 patients per condition).
Changes in key outcomes will be assessed comparing
patient data collected at baseline and six months
post-baseline. The primary outcome measures include
patients’ knowledge of CKD and the risks and bene-
fits of transplant and the capacity to make an
informed decision about transplant. Additionally, key
secondary measures will be examined, including
self-efficacy to pursue DDKT and LDKT and steps
taken towards transplant.
Comparisons in the two educational conditions’ effect-
iveness will also occur for patients earlier in the CKD
continuum, patients who speak Spanish, and non-White
patients.
Methodology Patients will be remunerated $20 with a
gift card after completing a baseline survey. Most sur-
veys will be completed online by the study participants
directly or over the phone with a trained interviewer.
Any mailed surveys will be returned to KPSC and en-
tered into the study’s assessment database. A
double-data entry method will be used to ensure accur-
ate data entry. Separate databases will be created for
each patient’s registration/contact information and as-
sessment data. Each patient will be given a unique, arbi-
trary study identification number that can be used to
associate their contact and registration information and
assessment data. Once the 1200 surveys have been col-
lected and entered, this data will be analyzed to
determine baseline differences in transplant knowledge,
informed decision-making, self-efficacy, and steps to-
ward transplant between patients varying in race/ethni-
city, primary language, and CKD stage before patients
are given an intervention.
Evaluation and statistical analysis plan
Power analysis
Based on the following assumptions, we estimated the
sample size for the RCT. Using data from previous RCTs
[4, 35], a mean knowledge change score of 1.0 points is
estimated necessary to be detected among patients re-
ceiving ET@Home and standard KPSC education. Pa-
tients’ baseline transplant knowledge scores will be
correlated with those of other patients from the same
clinics [intraclass correlation coefficient (ICC) of 0.31].
The variance in knowledge change has both between-
and within-cluster components, yielding a pooled stand-
ard deviation estimate of 4.0. Participant retention will
be 50% at the 6-month assessment. Outcomes will be
assessed using two-tailed statistical tests. Type 1 error
rate (alpha level) will be set at 0.05. This study design
will ensure power of 0.90. Power calculations for this
trial are based on all of these factors, which yields a
standardized effect size, accounting for clustering of ap-
proximately 0.257.
Power analyses based on changes in transplant know-
ledge, our primary study outcome, are presented. The
study design and analyses were treated as a test of the
difference between the mean knowledge score change of
CKD patients in the ET@Home and standard KPSC edu-
cation (control) conditions six months post-baseline. It
is estimated that with 600 completed surveys (50% attri-
tion), there will be a 90% power to detect a 0.25 effect
size between two equal-sized groups (control and treat-
ment groups). By stratifying recruitment and
randomization by race/ethnicity (Asian, Black, Hispanic,
White), primary language spoken (English vs. Spanish),
and stage of CKD, according to the table below, this
sample size will also have 90% power to detect 1 point
differences in change on the transplant knowledge scale
between the ET@Home and standard KPSC education
conditions for these critical subgroups using interaction
terms (e.g., treatment by race interaction, language by
race interaction). Patients enrolled and randomized are
shown in Table 3.
Measures
Demographic and clinical characteristics
Patient demographics, including patients’ gender, age,
race/ethnicity, preferred language, and CKD stage will
be obtained from the KPSC electronic medical record.
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Kidney transplant Derailers index
Measures common transplant derailers such as level of
education, health literacy, financial stability, neighbor-
hood/environmental safety, access to transportation, and
social support. Health literacy will be assessed with two
items measuring subjective health literacy that were
shown to detect health literacy as well as gold standard
measures such as the S-TOHFLA and the REALM [36].
Global Health-related quality of life
Global HRQOL will be measured with the PROMIS
10-item global health scale [37], which produces sum-
mary physical and mental scores, each of which has 4
items supported by factor analyses and IRT analyses,
with good reliabilities found: physical = 0.81, mental =
0.86.
Previous transplant education
The measure of previous transplant education captures
the quantity and quality of transplant education, and it
has been correlated with taking action toward pursuing
transplant in previous studies [26].
Small steps
A measure of whether patients took any of 25 steps to-
ward transplant (e.g., “Do you plan to talk through your
treatment options with people you trust?” or “Do you
plan to call the transplant center to begin evaluation?”).
At each survey, patients will be asked whether they had
“Already done,” “Plan to do,” or “Don’t plan to do” each
step. These questions will be completed at baseline and
six months.
Level of medical mistrust
Medical Mistrust will be measured with the Medical
Mistrust Index (MMI) [38]. This scale was supported by
factor analysis and exhibits moderately strong test-retest
reliability, with correlation coefficients ranging from
0.3–0.7.
LDKT and DDKT self-efficacy
The factor structure for the LDKT scale was verified
with exploratory and confirmatory factor analyses, dem-
onstrating a good fit for a one-factor solution (loadings
ranging between 0.61–0.91) [32]. The Cronbach’s alpha
was 0.88, indicating a high level of internal reliability.
The factor structure of the DDKT scale was also verified
with exploratory and confirmatory factor analyses, dem-
onstrating a good fit for a one-factor solution (loadings
ranging between 0.50–0.73) [39]. The alpha was 0.85, in-
dicating good internal consistency reliability.
Self-efficacy will be measured at baseline and six
months.
CKD, LDKT and DDKT knowledge
A knowledge scale was created using items our team has
employed in several previous studies and legacy mea-
sures [6, 35, 40] and new questions in response to issues
raised by patients and clinicians. A scale created from
the extant items has been evidenced with factor analyses
[41]. Knowledge will be measured at baseline and six
months.
Informed decision-making
An informed decision-making measure was created from
legacy measures and items generated from our formative
work. Items for this scale were selected from legacy
scales with good psychometric properties, like the Deci-
sional Conflict Scale, whose total scale and subscales evi-
dence high internal consistency, with Cronbach’s alphas
ranging between 0.6–0.9. There was not a statistically
significant difference between test-retest scores for this
scale, and there was a high correlation (r = 0.80) between
them [42]. Informed decision-making will be measured
at baseline and six months.
Process evaluation
At the six-month follow-up assessment, all intervention
participants will complete an evaluation of the helpful-
ness of and their satisfaction with the print and video
materials, text messages, and the ET@Home program as
a whole.
Statistical analysis
The available demographic and clinical characteristics of
patients who refuse to join the study will be compared
to those who enroll to determine if the patient selection
procedure has resulted in a biased sample. A similar
analysis will be conducted to compare the patients who
fail to complete the six-month assessment. Multiple im-
putation by chained equations (MICE) will be used to
multiply impute missing data. Imputation models will
include all analysis and stratification variables. The
intent-to-treat (ITT) approach will be applied in that all
Table 3 Patients enrolled and randomized
Race/Ethnicity/Language Stage of CKD
3a 4 5/ESRD Total
English-speaking Asian 67 67 66 200
English-speaking Black 67 66 67 200
English-speaking White 67 67 67 200
English-speaking Hispanic 67 67 66 200
Spanish-speaking Hispanic 133 133 134 400
Total 400 400 400 1200
a CKD 3 patient recruitment prioritized based on likelihood to progress
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study participants will be analyzed according to the
group that they were randomized to, regardless of
whether they actually received their assigned interven-
tion or not. Responses to the six-month intervention
evaluation will be summarized for the sample overall
and by levels of the stratification factors.
It is hypothesized that patients earlier in the CKD con-
tinuum, patients who speak Spanish, and non-White
patients will have less knowledge about the opportun-
ities for and risks and benefits of living kidney dona-
tion and will be making less-informed LDKT
decisions. Investigators will evaluate these hypotheses
using data from the pre-survey (baseline) by fitting
multilevel random effects models with a random
intercept to account for clustering at the CKD clinic
level to compare differences in knowledge, informed
decision-making, and Self-Efficacy. First, unadjusted
models will be examined with the race/ethnicity, pri-
mary language spoken, and stage of CKD as inde-
pendent variables for each test (separate models for
each). Then, each of these models will be adjusted for
other factors hypothesized to impact each outcome,
including level of socioeconomic vulnerability, the
level of previous transplant education received, the
level of medical mistrust, and the level of health liter-
acy. The addition of these variables will help test and
control for confounding.
Next, the effectiveness of ET@Home for CKD Stage 3–
5 patients to increase LDKT knowledge and decision-
making compared to KPSC education, by race/ethnicity
and primary language spoken, will be evaluated. First, it
will be determined if baseline differences in patient- and
clinic-level variables are present using χ2 and Wilcoxon
rank-sum tests, and subsequently adjustments for any
out-of-balance characteristics in outcome analyses will
be made. Differences in changes in transplant know-
ledge and Self-Efficacy using change scores, defined
as the difference between the baseline and
post-survey assessments, will be examined. Differences
in these outcomes between the educational conditions
will be tested using multilevel random effects models
with normal outcome distributions, accounting for
clustering with a random intercept for CKD clinic.
Differences in informed decision-making will be ex-
amined using multilevel random effects logistic
models. Finally, for the number of new steps taken,
differences between the educational conditions in the
count of new steps will be analyzed with a multilevel
random effects Poisson model.
After the primary analyses are completed, multi-
level random effects models will be constructed to
examine the heterogeneity of treatment effect (HTE)
using interaction terms for the ET@Home educa-
tional condition by the key patient subgroups by
which randomization was stratified, including race,
primary language spoken, and stage of CKD. For
example, the ET@Home educational condition
(ET@Home vs. SOC) x primary language (English vs.
Spanish) interaction term will be tested, enabling us
to determine of the ET@Home intervention was
more or less effective for primarily Spanish-speaking
patients than English-speaking patients.
Discussion
Previous research has shown that improved transplant
education, both inside and outside of transplant centers,
can increase patients’ knowledge of DDKT and LDKT,
pro-transplant attitudes, referral for transplant, and
LKDT rates [20, 27–29]. However, this RCT will allow
us the opportunity and ability to partner with KPSC, a
large healthcare system with a diverse patient base, to
compare ET@Home with their current educational
standard-of-care. We also will be able to assess a signifi-
cant amount of data from a fully integrated care man-
agement program, diverse membership, and ability to
track a large patient population as they make treatment
decisions along the most coordinated care system in the
country.
The four-part modular ET@Home program, delivered
to CKD 3–5 patients through video, print, and texting
systems over six months, is one of the first examinations
of supplementary education that does not involve
healthcare providers. This intervention also applies
health literacy and transplant education best practices
recommended for programs outside of transplant cen-
ters to deliver education directly to patients [34, 43, 44].
In addition, this RCT will examine the effectiveness of
this program on patients of various races, stages of
CKD, and primary languages spoken. The findings of
this trial will foster greater understanding of how Ex-
plore Transplant@Home specifically affects White, Black
and Hispanic patients’ LDKT decision-making, know-
ledge, and behavior. Additionally, as it will serve patients
whose primary language is English and Spanish, it will
allow us to learn more about their interest in preemptive
transplant, DDKT, and LDKT. We hope this program
will reduce disparities in access to transplant for patients
who speak Spanish and for Black, Hispanic, and Asian
patients served by KPSC.
Previous studies have identified low SES as a barrier to
transplant, with patients of low SES being less likely to be
wait-listed [45, 46]. Explore Transplant@Home is unique
in its ability to study the impact of SES on patients’ pur-
suit of LDKT. While previous studies have focused on SES
factors that are difficult to modify [13, 47] or on the neigh-
borhood or census block level [16, 47, 48], ET@Home will
assess key, specific SES barriers and provide support ser-
vices to address these barriers. This study will allow us to
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identify the most common SES-related influences challen-
ging completion of transplant evaluation and getting an
LDKT.
In conclusion, through this trial, investigators will gain
an understanding of key knowledge gaps for patients
along the CKD continuum and between patients who
speak different languages. An RCT examining the effect-
iveness of both English- and Spanish-language ET@Home
programs in increasing KPSC patients’ knowledge about
the opportunities for, and risks and benefits of, LDKT and
making informed transplant decisions will be completed.
Investigators will have a clear understanding of the facili-
tators and barriers occurring within the KPSC system to
the delivery of transplant and LDKT education for
patients of varying racial and socioeconomic groups. If
successful, the dissemination approach of ET@Home
could easily and immediately be expanded to other CKD
patients within KPSC and Kaiser Permanente Northern
California. The lessons learned and approach to dissemin-
ating this low-cost ET@Home educational approach could
be utilized within other healthcare and insurance compan-
ies, serving hundreds of thousands of diverse patients to
assist in their informed decision-making for DDKT and
LDKT before and after their kidneys fail. We hope this
ET@Home program will help to reduce disparities in ac-
cess to transplant and creates a model to be replicated for
other healthcare systems.
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